8 May 2025

Pharmaceuticals Prostate cancer

Combination therapy shows promise for prostate cancer

24 April 2025

Cancer PBS

Aussie myelofibrosis drug added to PBS

10 April 2025

Leukaemia Pharmaceuticals

Real-world data backs AML treatment

10 April 2025

Hepatocellular carcinoma Research

Three treatments are better than one for liver cancer

10 April 2025

Breast cancer TGA

Ribociclib welcomed in by TGA

27 March 2025

Hospitals Pharmaceuticals

Deprescribe, use the patient’s stash and shrink starter packs

27 March 2025

Technology TGA

TGA and international partners prioritise joint product reviews

27 February 2025

Pharmaceuticals TGA

TGA gives tislelizumab the thumbs up

27 February 2025

Leukaemia Pharmaceuticals

Infusion therapy for CLL could be a thing of the past

13 February 2025

Immunosuppression Pharmaceuticals

Use antivirals in patients at risk of hep B reactivation

12 December 2024

Diabetes Obesity

Even more things GLP-1 RAs can do

28 November 2024

Cancer Genetics Research

More gene testing means safer medication

31 October 2024

Pharmaceuticals Sarcoidosis

What we neglect in sarcoidosis care

17 October 2024

Pharmaceuticals Rare cancers

Breast cancer drug also work for appendiceal cancer

5 September 2024

PBS Pharmaceuticals

Expanded PBS listing for cabozantinib

5 September 2024

Obesity Pharmaceuticals Surgery

Bariatric surgery declining amid rise of GLP-1 RAs

22 August 2024

Pain Pharmaceuticals

Choice of first opioid predicts long-term use

27 June 2024

Pharmaceuticals Systems

Weight-based pembrolizumab gives more bang for the public buck

13 June 2024

Diabetes PBS Pharmaceuticals Political

PBS rejigs rules on GLP-1s and other diabetes meds

30 May 2024

Pain Pharmaceuticals

Opioids on the silver screen